RBM12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.686210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.664600E-01
Normal-vs-Stage2
1.548020E-01
Normal-vs-Stage3
1.199210E-01
Normal-vs-Stage4
6.440000E-01
Stage1-vs-Stage2
6.697000E-01
Stage1-vs-Stage3
1.408380E-02
Stage1-vs-Stage4
1.486310E-02
Stage2-vs-Stage3
1.300560E-01
Stage2-vs-Stage4
1.144410E-02
Stage3-vs-Stage4
3.104200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.636970E-01
Normal-vs-AfricanAmerican
7.087000E-01
Normal-vs-Asian
1.355160E-01
Caucasian-vs-AfricanAmerican
2.794800E-01
Caucasian-vs-Asian
3.026400E-01
AfricanAmerican-vs-Asian
1.647630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.107200E-01
Normal-vs-Female
1.421780E-01
Male-vs-Female
9.593800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.531800E-01
Normal-vs-Age(41-60Yrs)
4.060800E-01
Normal-vs-Age(61-80Yrs)
1.307600E-01
Normal-vs-Age(81-100Yrs)
3.590800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.206200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.249400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.824200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.170100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.916400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.284600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.913600E-02
Normal-vs-Daily Drinker
9.779800E-02
Normal-vs-Weekly Drinker
1.780610E-01
Normal-vs-Occasional Drinker
5.216200E-01
Normal-vs-Social Drinker
3.760400E-01
Non Drinker-vs-Daily Drinker
8.677000E-01
Non Drinker-vs-Weekly Drinker
5.307200E-01
Non Drinker-vs-Occasional Drinker
2.489600E-02
Non Drinker-vs-Social Drinker
1.400620E-01
Daily Drinker-vs-Weekly Drinker
6.741600E-01
Daily Drinker-vs-Occasional Drinker
6.504300E-02
Daily Drinker-vs-Social Drinker
2.412200E-01
Weekly Drinker-vs-Occasional Drinker
2.044200E-01
Weekly Drinker-vs-Social Drinker
4.900000E-01
Occasional Drinker-vs-Social Drinker
5.916000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.638600E-01
Normal-vs-Grade 2
6.308200E-02
Normal-vs-Grade 3
6.739800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.150000E-01
Grade 1-vs-Grade 3
2.978000E-01
Grade 1-vs-Grade 4
2.638600E-01
Grade 2-vs-Grade 3
5.333200E-01
Grade 2-vs-Grade 4
6.308200E-02
Grade 3-vs-Grade 4
6.739800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.250570E-01
Normal-vs-NonDiabetic
1.189360E-01
Diabetic-vs-NonDiabetic
5.164000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.256600E-01
Normal-vs-NoPancreatitis
1.538440E-01
Pancreatitis-vs-NoPancreatitis
4.922100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.443200E-01
Normal-vs-N1
1.578400E-01
N0-vs-N1
8.532600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.154800E-01
Normal-vs-TP53-NonMutant
2.371200E-01
TP53-Mutant-vs-TP53-NonMutant
4.592200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
